Dr Ross Richard Melvin, DO - Medicare Interventional Cardiology in Panama City, FL

Dr Ross Richard Melvin, DO is a medicare enrolled "Internal Medicine - Interventional Cardiology" physician in Panama City, Florida. He went to Michigan State University College Of Osteopathic Medicine and graduated in 2012 and has 12 years of diverse experience with area of expertise as Interventional Cardiology. He is a member of the group practice Econfina Cardiology Group Pa and his current practice location is 625 W Baldwin Rd Ste C, Panama City, Florida. You can reach out to his office (for appointments etc.) via phone at (850) 769-0329.

Dr Ross Richard Melvin is licensed to practice in Florida (license number OS19614) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1871856492.

Contact Information

Dr Ross Richard Melvin, DO
625 W Baldwin Rd Ste C,
Panama City, FL 32405-3359
(850) 769-0329
(844) 563-8135



Physician's Profile

Full NameDr Ross Richard Melvin
GenderMale
SpecialityInterventional Cardiology
Experience12 Years
Location625 W Baldwin Rd Ste C, Panama City, Florida
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Dr Ross Richard Melvin attended and graduated from Michigan State University College Of Osteopathic Medicine in 2012
  NPI Data:
  • NPI Number: 1871856492
  • Provider Enumeration Date: 06/19/2012
  • Last Update Date: 06/22/2023
  Medicare PECOS Information:
  • PECOS PAC ID: 5294979316
  • Enrollment ID: I20230413002574

Medical Identifiers

Medical identifiers for Dr Ross Richard Melvin such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1871856492NPI-NPPES
OS19614OtherFLFLORIDA MEDICAL LICENSE

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
208D00000XGeneral Practice 5101020121 (Michigan)Secondary
207RI0011XInternal Medicine - Interventional Cardiology OS19614 (Florida)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Ascension Sacred Heart BayPanama city, FLHospital
Gulf Coast Regional Medical CenterPanama city, FLHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Econfina Cardiology Group Pa084018020416

News Archive

Scientists uncover TDP-43 protein as possible target for treatment of ALS, FTD

Neuroscientists at Georgetown University Medical Center say they have new evidence that challenges scientific dogma involving two fatal neurodegenerative diseases - amyotrophic lateral sclerosis (ALS), and frontotemporal dementia (FTD) - and, in the process, have uncovered a possible therapeutic target as a novel strategy to treat both disorders.

Low molecular weight heparins inhibit SARS-CoV-2 cell invasion

A recent paper available on the preprint server bioRxiv* reports preliminary data on the ability of low molecular weight heparins to interact with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), elicit structural changes in its key proteins and subsequently halt cell invasion.

Findings suggest that a prosaposin-based drug could block metastasis spread

By studying the roles two proteins, thrombospondin-1 and prosaposin, play in discouraging cancer metastasis, a trans-Atlantic research team has identified a five-amino acid fragment of prosaposin that significantly reduces metastatic spread in mouse models of prostate, breast and lung cancer.

Oncology drug development services: an interview with Dr. Jean-Pierre Wery, President of Crown Bioscience, Inc.

Crown serves pharmaceutical companies and biotech companies. We have two areas of focus: oncology and metabolic diseases. In the oncology space we focus on pre-clinical services. Essentially, we have all the tools to help our customers move from target discovery, target validation, to a clinical candidate.

Home learning environment influences academic success of children

Children whose parents provide them with learning materials like books and toys and engage them in learning activities and meaningful conversations in infancy and toddlerhood are likely to develop early cognitive skills that can cascade into later academic success, finds a new study by NYU's Steinhardt School of Culture, Education, and Human Development.

Read more Medical News

› Verified 9 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Ross Richard Melvin allows following entities to bill medicare on his behalf.
Entity NameEconfina Cardiology Group Pa
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1609801257
PECOS PAC ID: 0840180204
Enrollment ID: O20040318000844

News Archive

Scientists uncover TDP-43 protein as possible target for treatment of ALS, FTD

Neuroscientists at Georgetown University Medical Center say they have new evidence that challenges scientific dogma involving two fatal neurodegenerative diseases - amyotrophic lateral sclerosis (ALS), and frontotemporal dementia (FTD) - and, in the process, have uncovered a possible therapeutic target as a novel strategy to treat both disorders.

Low molecular weight heparins inhibit SARS-CoV-2 cell invasion

A recent paper available on the preprint server bioRxiv* reports preliminary data on the ability of low molecular weight heparins to interact with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), elicit structural changes in its key proteins and subsequently halt cell invasion.

Findings suggest that a prosaposin-based drug could block metastasis spread

By studying the roles two proteins, thrombospondin-1 and prosaposin, play in discouraging cancer metastasis, a trans-Atlantic research team has identified a five-amino acid fragment of prosaposin that significantly reduces metastatic spread in mouse models of prostate, breast and lung cancer.

Oncology drug development services: an interview with Dr. Jean-Pierre Wery, President of Crown Bioscience, Inc.

Crown serves pharmaceutical companies and biotech companies. We have two areas of focus: oncology and metabolic diseases. In the oncology space we focus on pre-clinical services. Essentially, we have all the tools to help our customers move from target discovery, target validation, to a clinical candidate.

Home learning environment influences academic success of children

Children whose parents provide them with learning materials like books and toys and engage them in learning activities and meaningful conversations in infancy and toddlerhood are likely to develop early cognitive skills that can cascade into later academic success, finds a new study by NYU's Steinhardt School of Culture, Education, and Human Development.

Read more Medical News

› Verified 9 days ago

Entity NameCardiovascular Institute Of Nw Florida Center Of Excellence, Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1639898380
PECOS PAC ID: 7214302884
Enrollment ID: O20230413000003

News Archive

Scientists uncover TDP-43 protein as possible target for treatment of ALS, FTD

Neuroscientists at Georgetown University Medical Center say they have new evidence that challenges scientific dogma involving two fatal neurodegenerative diseases - amyotrophic lateral sclerosis (ALS), and frontotemporal dementia (FTD) - and, in the process, have uncovered a possible therapeutic target as a novel strategy to treat both disorders.

Low molecular weight heparins inhibit SARS-CoV-2 cell invasion

A recent paper available on the preprint server bioRxiv* reports preliminary data on the ability of low molecular weight heparins to interact with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), elicit structural changes in its key proteins and subsequently halt cell invasion.

Findings suggest that a prosaposin-based drug could block metastasis spread

By studying the roles two proteins, thrombospondin-1 and prosaposin, play in discouraging cancer metastasis, a trans-Atlantic research team has identified a five-amino acid fragment of prosaposin that significantly reduces metastatic spread in mouse models of prostate, breast and lung cancer.

Oncology drug development services: an interview with Dr. Jean-Pierre Wery, President of Crown Bioscience, Inc.

Crown serves pharmaceutical companies and biotech companies. We have two areas of focus: oncology and metabolic diseases. In the oncology space we focus on pre-clinical services. Essentially, we have all the tools to help our customers move from target discovery, target validation, to a clinical candidate.

Home learning environment influences academic success of children

Children whose parents provide them with learning materials like books and toys and engage them in learning activities and meaningful conversations in infancy and toddlerhood are likely to develop early cognitive skills that can cascade into later academic success, finds a new study by NYU's Steinhardt School of Culture, Education, and Human Development.

Read more Medical News

› Verified 9 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Ross Richard Melvin is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr Ross Richard Melvin, DO
625 W Baldwin Rd Ste C,
Panama City, FL 32405-3359

Ph: (850) 769-0329
Dr Ross Richard Melvin, DO
625 W Baldwin Rd Ste C,
Panama City, FL 32405-3359

Ph: (850) 769-0329

News Archive

Scientists uncover TDP-43 protein as possible target for treatment of ALS, FTD

Neuroscientists at Georgetown University Medical Center say they have new evidence that challenges scientific dogma involving two fatal neurodegenerative diseases - amyotrophic lateral sclerosis (ALS), and frontotemporal dementia (FTD) - and, in the process, have uncovered a possible therapeutic target as a novel strategy to treat both disorders.

Low molecular weight heparins inhibit SARS-CoV-2 cell invasion

A recent paper available on the preprint server bioRxiv* reports preliminary data on the ability of low molecular weight heparins to interact with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), elicit structural changes in its key proteins and subsequently halt cell invasion.

Findings suggest that a prosaposin-based drug could block metastasis spread

By studying the roles two proteins, thrombospondin-1 and prosaposin, play in discouraging cancer metastasis, a trans-Atlantic research team has identified a five-amino acid fragment of prosaposin that significantly reduces metastatic spread in mouse models of prostate, breast and lung cancer.

Oncology drug development services: an interview with Dr. Jean-Pierre Wery, President of Crown Bioscience, Inc.

Crown serves pharmaceutical companies and biotech companies. We have two areas of focus: oncology and metabolic diseases. In the oncology space we focus on pre-clinical services. Essentially, we have all the tools to help our customers move from target discovery, target validation, to a clinical candidate.

Home learning environment influences academic success of children

Children whose parents provide them with learning materials like books and toys and engage them in learning activities and meaningful conversations in infancy and toddlerhood are likely to develop early cognitive skills that can cascade into later academic success, finds a new study by NYU's Steinhardt School of Culture, Education, and Human Development.

Read more News

› Verified 9 days ago


Internal Medicine Doctors in Panama City, FL

William W Dent, MD
Internal Medicine
Medicare: Not Enrolled in Medicare
Practice Location: 801 E 6th St, Suite 201, Panama City, FL 32401
Phone: 850-763-8680    Fax: 850-763-8690
Jean-edson Belcourt, M.D
Internal Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 449 W 23rd St, Panama City, FL 32405
Phone: 850-767-2100    Fax: 850-769-8341
Rayen-ayoub Chakra,
Internal Medicine
Medicare: Medicare Enrolled
Practice Location: 1710 Lisenby Ave, Panama City, FL 32405
Phone: 850-807-4420    Fax: 850-862-0605
William D Bone, M.D.
Internal Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 2579 Huntcliff Ln, Panama City, FL 32405
Phone: 850-763-8596    Fax: 850-784-6774
Crystal Maria Jones, M.D.
Internal Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 3232 E 15th St, Panama City, FL 32405
Phone: 850-532-5157    
Dr. Dinesh K Bhatt, M.D.
Internal Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 2567 Huntcliff Ln, Panama City, FL 32405
Phone: 850-215-7117    Fax: 850-913-8956
Dr. Brian May Feijoo, MD
Internal Medicine
Medicare: Medicare Enrolled
Practice Location: 615 N Bonita Ave, Panama City, FL 32401
Phone: 850-769-1511    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.